International Patent: ANTISENSE OLIGONUCLEOTIDE WHICH PROMOTES TRPV1 GENE EXON 7 SKIPPING, AND USE IN PREPARING DRUG WHICH TREATS CHRONIC PAIN

GENEVA, Sept. 24 -- ASOCURA PHARMACEUTICALS GUANGZHOU CO., LTD filed a patent application (CN2026/092714) for “ANTISENSE OLIGONUCLEOTIDE WHICH PROMOTES TRPV1 GENE EXON 7 SKIPPING, AND USE IN PREPARING DRUG WHICH TREATS CHRONIC PAIN”. With publication no. WO/2026/195082, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....